# Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 38.87% Upside Potential

- Link: https://www.directorstalkinterviews.com/merit-medical-systems-inc-mmsi-stock-analysis-strong-buy-ratings-and-38-87-upside-potential/4121253224
- Published: 2026-06-08T10:20:47+01:00
- Author: Madison Wilson

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands as a formidable player in the 
healthcare sector, specifically within the medical instruments and supplies industry.
Headquartered in South Jordan, Utah, the company is renowned for its innovative 
single-use medical products that support interventional, diagnostic, and therapeutic
procedures globally. With a market capitalization of $3.85 billion, Merit Medical
Systems has firmly established itself in the medical technology landscape.

Currently trading at $64.48, MMSI’s stock price hovers near the lower end of its
52-week range of $60.31 to $96.01. This presents an intriguing entry point for investors,
particularly given the company’s strong growth prospects. Analysts are optimistic,
assigning the stock an average target price of $89.55, suggesting a potential upside
of nearly 38.87%.

The company’s valuation metrics present a mixed picture. While the trailing P/E 
ratio and other typical valuation ratios are not available, analysts project a forward
P/E of 14.66, indicating expectations of earnings growth. This expectation is supported
by the company’s revenue growth of 7.50% and earnings per share (EPS) of $2.32. 
Additionally, Merit Medical’s return on equity (ROE) of 9.12% reflects a respectable
level of efficiency in generating returns from shareholders’ equity.

One of the key financial strengths of Merit Medical is its robust free cash flow,
reported at approximately $178.19 million. This financial health underscores the
company’s ability to reinvest in its business, pursue strategic acquisitions, and
potentially return value to shareholders through buybacks or dividends, although
the current dividend yield is not applicable.

Analyst sentiment towards MMSI remains overwhelmingly positive, with 9 buy ratings
and just 2 hold ratings. The absence of sell ratings highlights the confidence analysts
have in the company’s strategic direction and market positioning. The target price
range between $74.00 and $110.00 further emphasizes the stock’s potential for appreciation.

From a technical perspective, MMSI is currently trading below both its 50-day and
200-day moving averages, which stand at $65.60 and $78.67, respectively. The relative
strength index (RSI) of 41.48 suggests that the stock is approaching oversold territory,
potentially offering a buying opportunity for investors seeking to capitalize on
market fluctuations. The MACD and signal line, both in negative territory, may indicate
short-term bearish momentum, but longer-term prospects appear promising given the
company’s fundamentals and market potential.

Merit Medical Systems continues to innovate across its Cardiovascular and Endoscopy
segments, offering a wide array of products for critical medical procedures. The
company’s global reach, spanning markets in the United States, China, and Europe,
among others, positions it well to capitalize on the growing demand for advanced
medical solutions.

For individual investors, Merit Medical Systems, Inc. presents a compelling investment
opportunity. With strong buy ratings, a significant potential upside, and solid 
financial underpinnings, MMSI is well-suited for those looking to invest in a company
with a consistent track record of growth and innovation in the healthcare sector.
As the company continues to expand its product offerings and strengthen its global
presence, investors could see substantial returns in the coming years.

Share on: